-
March 16, 2023 ‘Right To Try Laws’ and Legal Access to Psilocybin Therapy with Dr. Jonathan FieldsPetitioning the DEA to respect the ‘Right to Try Laws’ which empower terminally ill patients...
-
August 26, 2022 Breaking: DEA Backs Off, Won’t Criminalize Two New PsychedelicsThe DEA backs off announces they are withdrawing a proposed rule to ban the psychedelic...
-
August 23, 2022 The DEA is Attempting to Ban Two New Psychedelic DrugsThe DEA moves to ban two obscure psychedelic drugs, DOI and DOC, amidst ongoing calls...
-
August 12, 2022 DEA Under Pressure from Terminally Ill “Right to Try” Psychedelic AdvocatesThe DEA is denying psilocybin therapy for dying patients despite the Right To Try Act....
-
July 28, 2022 The DEA Backs Down, Will Not Criminalize 5 PsychedelicsThis week the DEA announced it would withdraw its plan to schedule 5 research psychedelics....
-
February 15, 2022 Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More PsychedelicsBiotech companies and researchers opposed to five more tryptamines becoming schedule 1 controlled substances will...
-
January 20, 2022 DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled SubstancesAgency argues these five tryptamines "have no known medical use," setting up a showdown with...
-
December 2, 2021 DEA Boosts Psychedelics Production (Again) to Meet Research DemandDrug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline...
-
November 15, 2021 DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production QuotasDrug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide...
-
September 2, 2021 DEA Proposes Huge Increase to Psilocybin and Psilocin Quotas for Research PurposesIn its proposed revised 2021 quotas, the DEA suggests 4900% increase in the allowed quantities...
